Rheumatoid arthritis. Triple therapy or etanercept after methotrexate failure in RA?
Where this comes from
- Record sourced from PubMed, PMID 23897440.
- Also identified by DOI 10.1038/nrrheum.2013.118.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Since the 1990s, patients with rheumatoid arthritis have been treated with at least one DMARD. Methotrexate, which is usually the first-line treatment, elicits good or even excellent clinical results in 20–30% of patients—but in most patients it does not. Thus, an important question is what to do after methotrexate failure.
Medical subject headings
- Antirheumatic Agents
- Arthritis, Rheumatoid
- Hydroxychloroquine
- Immunoglobulin G
- Methotrexate
- Receptors, Tumor Necrosis Factor
- Sulfasalazine